Misspelled Author Name and Funding Source

No authors listed

Published Erratum

No authors listed. JAMA Oncol. 2021.

. 2021 Feb 1;7(2):312.

doi: 10.1001/jamaoncol.2020.7373.

No abstract available

Erratum for

Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome.
Samadder NJ, Riegert-Johnson D, Boardman L, Rhodes D, Wick M, Okuno S, Kunze KL, Golafshar M, Uson PLS Jr, Mountjoy L, Ertz-Archambault N, Patel N, Rodriguez EA, Lizaola-Mayo B, Lehrer M, Thorpe CS, Yu NY, Esplin ED, Nussbaum RL, Sharp RR, Azevedo C, Klint M, Hager M, Macklin-Mantia S, Bryce AH, Bekaii-Saab TS, Sekulic A, Stewart AK. Samadder NJ, et al. JAMA Oncol. 2021 Feb 1;7(2):230-237. doi: 10.1001/jamaoncol.2020.6252. JAMA Oncol. 2021. PMID: 33126242 Free PMC article.

1. Samadder NJ, Riegert-Johnson D, Boardman L, et al. . Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome. JAMA Oncol. Published online October 30, 2020. doi:10.1001/jamaoncol.2020.6252 - DOI - PMC - PubMed